Welcome to our dedicated page for OMADA HEALTH news (Ticker: OMDA), a resource for investors and traders seeking the latest updates and insights on OMADA HEALTH stock.
Omada Health, Inc. (Nasdaq: OMDA) is a virtual-first, between-visit healthcare provider focused on cardiometabolic conditions such as diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. The OMDA news page on Stock Titan aggregates company announcements, clinical updates, product news, and financial disclosures so readers can follow how Omada’s virtual care platform and GLP-1 programs evolve over time.
News about Omada Health frequently covers quarterly and annual financial results, including revenue trends, member growth, and updates shared through earnings press releases and related Form 8-K filings. Investors can also see announcements about Omada’s participation in major healthcare and investor conferences, where senior management presents the company’s strategy and performance.
Because Omada operates in digital chronic care and GLP-1 support, its news flow also includes clinical and real-world evidence analyses from Omada’s GLP-1 Care Tracks and Enhanced GLP-1 Care Track, along with updates from the Omada Insights Lab ANSWERS Initiative. These releases describe findings on medication persistence, weight outcomes, and weight maintenance after GLP-1 discontinuation for members enrolled in Omada programs.
Product and platform updates are another recurring theme, such as the launch of Meal Map, an AI-powered nutrition experience focused on nutrient quality, and announcements about OmadaSpark, the company’s AI-powered nutrition education tool. Omada also issues news about its prescribing and medication management capability for anti-obesity medications, including GLP-1s, and about enhancements to its AI-enabled support tools.
By reviewing the OMDA news feed, readers can track how Omada’s member base, customer relationships, GLP-1-related offerings, and AI-powered capabilities are described in official communications, and how the company positions its role in chronic care and virtual healthcare delivery.
Omada Health (Nasdaq: OMDA) will release its second quarter 2026 financial results on Thursday, August 6, 2026, after market close. Management will host a conference call at 4:30 p.m. ET the same day, with a live audio webcast and replay available on the company’s investor relations website.
Omada Health (Nasdaq: OMDA) will release its 2026 quarterly financial results on Thursday, August 6, 2026, after market close, and hold a conference call at 4:30 p.m. ET to review the results.
A live audio webcast and a replay (available for about 12 months) will be accessible via the Omada Health investor relations website, with optional pre-registration for the conference call through an online link.
Omada Health (Nasdaq: OMDA) announced it will host its first Investor Day on Thursday, September 10, 2026, beginning at 1:00 pm EDT in New York City. The half-day, in-person event will feature senior management discussing Omada’s vision, strategy, and long-term growth plans, with live webcast access and replay available via the company’s investor relations website.
Omada Health (Nasdaq: OMDA) announced that senior management will participate in Canaccord Genuity’s 46th Annual Growth Conference in Boston. The appearance includes a fireside chat on Tuesday, August 11, at 8:00 a.m. EDT, with a live webcast and replay available at Omada Health’s investor relations events webpage.
Omada Health (NASDAQ: OMDA) joined the Digital Medicine Society (DiMe) as title sponsor of the Post-Contracting Operational Readiness for Virtual-First Care project. The 3.5‑month initiative will build a toolkit that helps payers and virtual-first providers integrate, list, and reimburse contracted virtual care within 90 days.
Omada Health (Nasdaq: OMDA) announced that senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami. The appearance includes a fireside chat on Wednesday, June 10, at 8:20 a.m. PST, with a live webcast and replay available online.
Omada Health (Nasdaq: OMDA) will join Eli Lilly’s Employer Connect as an independent program administrator to offer its GLP-1 Care Track to employers, adding a direct-to-employer channel alongside PBM and cash-pay pathways.
The integration provides transparent net cost for Zepbound, defined employer contribution levels, and options to pair medications with ongoing lifestyle support. Omada cites a survey of >3,000 GLP-1 patients showing coverage gaps, rising out-of-pocket costs, and high demand for nutrition and exercise support while on therapy.
Omada Health (Nasdaq: OMDA) reported Q1 2026 results for the quarter ended March 31, 2026. Total Members reached 1.02 million (up 51% YoY). Revenue was $78.0 million (up 42% YoY). Gross margin was 62% (non-GAAP 64%). Net loss narrowed to $3.0 million; adjusted EBITDA was $1.0 million. Cash and cash equivalents were $212 million. Omada added Optum Rx collaboration and now has relationships with the nation’s three leading PBMs. 2026 guidance: revenue $322–$330 million (midpoint +25% vs 2025); adjusted EBITDA $14–$20 million (midpoint ~3x 2025).
Omada Health (Nasdaq: OMDA) reported 12-week study results showing its GLP-1 Care Track members lost more weight and improved body composition versus controls. Omada members lost 6.0% of starting weight versus 3.3% for controls, reduced body fat by 3.3% (about 2x controls), and increased muscle mass percentage nearly threefold.
The 245-adult study (151 Omada, 94 control) also found better mental health, physical function, and confidence among Omada participants.
Omada Health (Nasdaq: OMDA) will release its first quarter 2026 financial results on May 7, 2026 after market close and host a conference call the same day at 4:30 pm ET.
A live audio webcast will be available at the company investor site, with a replay accessible for approximately 12 months. Participants may pre-register for the call via the provided registration link.